Moderna, Inc. (MRNA)

352.43
16.08 4.36
NASDAQ
Prev Close 368.51
Open 351.58
Day Low/High 337.29 / 357.64
52 Wk Low/High 102.66 / 497.49
Volume 25.08M
Exchange NASDAQ
Shares Outstanding 405.45B
Market Cap 133.65B
P/E Ratio N/A
Div & Yield N.A. (N.A)

Moderna Cut to Market Perform at BMO

Masks on a Wall, Moderna, What Rotation?, Tesla and the S&P 500, Trading Walmart

Masks on a Wall, Moderna, What Rotation?, Tesla and the S&P 500, Trading Walmart

They called it rotation. I'm still not completely convinced. Don't you normally have to sell something to rotate?

Market Gets Shot in the Arm, but Side Effects Still Unknown

Market Gets Shot in the Arm, but Side Effects Still Unknown

Be aware that major rotation is going on and listen to arguments that optimism over a vaccine might be too high.

Jim Cramer: You Gotta Have Faith

Jim Cramer: You Gotta Have Faith

As the Dow hits an all-time high while a pandemic rages on, who are those willing to look through the valley to the good numbers?

Will Moderna's Vaccine Trigger the Same Response as Pfizer's Did?

Will Moderna's Vaccine Trigger the Same Response as Pfizer's Did?

The rotational nature of this action is making for some tricky trading.

Don't Fight the Trend - But Beware of Chasing

Don't Fight the Trend - But Beware of Chasing

Pursuing stocks that are extended may prove regrettable.

Here's How I'm Trading Moderna Right Now

Here's How I'm Trading Moderna Right Now

I'm long MRNA and have been since the beginning of the pandemic.

A Second Vaccine Triggers Another Round of Rotational Action

A Second Vaccine Triggers Another Round of Rotational Action

How much chasing do we want to do at this point?

It May Be Time to Be a Contrarian Again... And Sell/Short on Favorable Moderna Vaccine Efficacy

* Buy the rumor (S&P futures +42 handles), sell the news? * Look for Ss (S and P) over Ns (Nasdaq) as Moderna's great vaccine news will hasten the pivot from growth to value * Look to value investments - banks (my favorite group) and other beneficia...

Marketplace Uncertainties, Problematic Covid, Retailers' Earnings, Week Ahead

Marketplace Uncertainties, Problematic Covid, Retailers' Earnings, Week Ahead

The only expectation that I have for now is a near certainty in increased volatility caused by several factors.

Words Matter, Central Bankers Speak, Crypto Thoughts, 3 Nice Earnings Surprises

Words Matter, Central Bankers Speak, Crypto Thoughts, 3 Nice Earnings Surprises

Comments by Mitch McConnell, Jerome Powell and Christine Lagarde had impacts on the market Thursday.

Jim Cramer: This Is All Playing Out Like a Stephen King Novel

Jim Cramer: This Is All Playing Out Like a Stephen King Novel

What happens when everyone hunkers down, creating their own de facto stay-in-place lockdown?

Indecisive Markets, RealClearPolitics, Infection Surge, Moderna, Disney Earnings

Indecisive Markets, RealClearPolitics, Infection Surge, Moderna, Disney Earnings

Trading volume was low enough Wednesday to indicate a lack of conviction, or conviction that did not spread across enough managers to truly change the narrative.

Reviewing the Markets, Spreading Covid-19, Vaccine Politics, My Boeing Plan

Reviewing the Markets, Spreading Covid-19, Vaccine Politics, My Boeing Plan

Just how many markets are there? We used to say 'the market' was up or down by so many points. No more.

Vaccine Rotation, What I Bought and Sold, Stocks on Thin Ice, Apple's Event

Vaccine Rotation, What I Bought and Sold, Stocks on Thin Ice, Apple's Event

What the Nasdaq experienced Monday is known not just as an 'Outside Day,' but an 'Outside Reversal,' and these can be dangerous.

Pfizer's Ureka Moment and Why Winning Is Never Boring

Pfizer's Ureka Moment and Why Winning Is Never Boring

The leaders now are suddenly the reopening stocks, while the work remotely and stay at home stocks are being sold.

I'm Long Moderna and Here's Why

I'm Long Moderna and Here's Why

The focus when it comes to MRNA is the timing of mRNA-1273, the firm's two dose hopeful protection against Covid.

Nasty Mix, Lockdown Anxiety, Measuring the Fears, Super Bowl of Tech Earnings

Nasty Mix, Lockdown Anxiety, Measuring the Fears, Super Bowl of Tech Earnings

In plain speak, they ran for the exits on Wednesday, This week has been a period of intense institutional distribution.

4 Straight Days, Troubling Trend?, Dollar Weakness, FDA Meets, Pfizer Vaccine

4 Straight Days, Troubling Trend?, Dollar Weakness, FDA Meets, Pfizer Vaccine

Several sessions over the past 10 days have seen increased trading volume at the NYSE, but not the Nasdaq, and for the S&P 500, but not the Nasdaq Composite. Is this professional risk reduction?

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

3 'Pick & Shovel' Stock Plays in Covid Vaccine Development

Investors are chasing every name that's developing a promising coronavirus vaccine. These stocks will be winners no matter which companies are successful.

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid Drug Candidates, Buy Eli Lilly? Large Cap Stocks, Tesla Debt Upgrade

Covid itself, and therapeutics or vaccines associated with taking on the SARS-CoV-2 coronavirus, is under a public microscope.

Pelosi's Hardball Gambit, Playing Small Ball, Promising Vaccine Outlook

Pelosi's Hardball Gambit, Playing Small Ball, Promising Vaccine Outlook

Plus, there's talk of a possible combination of Advanced Micro Devices and Xilinx.

Stimulus Repercussions, Is the Equities Rally Dead? Antitrust Action, Apple 5G

Stimulus Repercussions, Is the Equities Rally Dead? Antitrust Action, Apple 5G

One day after deciding that we still could not confirm the market's uptrend, we are forced to ask the opposite.

The Investment Angle of Covid-19

The Investment Angle of Covid-19

Stocks of companies that have Covid-19 vaccine candidates have boomed while those in the treatment space have not.

DC Do-Over, October Volatility, Positive Technicals, Datadog Breakout, Moderna

DC Do-Over, October Volatility, Positive Technicals, Datadog Breakout, Moderna

Suddenly, both sides realize that they have played politics and the people had noticed. Not those two from Tuesday night. Thankfully.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Jim Cramer: You Heard the Ugly of the Debate. Here's the Good.

Neither candidate seems to be the enemy of the market -- at least not yet.

With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?

With Q3 Earnings Up Ahead, Can Johnson & Johnson Set the Table?

I see no reason to flee this name, therefore, I am not.

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

Certainty of Uncertainty, Lines in the Sand, Election Fears, Fed Alone, Twitter

The result has been a technical breakdown in risk-asset pricing -- and the main culprit is without a doubt, the inability of Congress to compromise.

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

Veeva and RedHill: 2 Stocks to Consider as They Team Up to Battle Covid-19

RedHill Biopharma has adopted 'Veeva Vault CDMS', Veeva's modern cloud platform.

What's Happening Now Is a Change in Institutional Investor Mindset

What's Happening Now Is a Change in Institutional Investor Mindset

Being scared of a pullback isn't 'expensive' or 'stupid'. It's just good investing.